Scancell
Samantha joined Scancell from Immunocore where she held several positions including Head of T Cell Cloning and Group Leader. While at Immunocore, Samantha was responsible for the generation of the in-house T cell cloning method and biological molecule discovery which made significant contributions to the current Immunocore oncology pipeline. Prior to this, Samantha held a number of positions at Medigene, Avidex, NIBSC, and GSK. Samantha holds a Ph.D. from University College London in Immunology/Haematology, following a BSc Honours Degree in Microbiology from the University of Sheffield.
Scancell
Scancell's mission is to overcome this breach in defenses by developing products that stimulate the immune system to treat or prevent cancer.